Findings in Amino Acids Reported from Novartis Pharma HispanicBusiness.com Our news journalists obtained a quote from the research from Novartis Pharma, "Here we report the characterization of a proposed biosimilar rituximab (GP2013) and originator rituximab. To compare GP2013 with originator rituximab using an extensive ... |
